Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

Summary

This pilot phase II trial studies how well photodynamic therapy works in treating patients with mycosis fungoides that does not respond to treatment. Photodynamic therapy uses a drug, such as aminolevulinic acid hydrochloride, that becomes active when it is exposed to light. The activated drug may kill cancer cells.

Timeline

Start

2017-11-13

Primary completion

2020-02-25

Completion

2020-08-12

Drugs

Indications